Abstract
In patients with rheumatoid arthritis (RA), TNFα inhibitors may confer an increased risk for non-tuberculous infection.1 Some studies found no increase in infection rate,2,3 whereas others found increased risk of serious infections.4,5 We prospectively studied serious infections in RA patients treated with TNFα inhibitors in a single Rheumatology Center. All 269 patients with RA followed up in the Rheumatology Clinic of the University General Hospital of Larisa from January 2002 to September 2007 were included in the study.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call